Company research / PTPI
Petros Pharmaceuticals, Inc. (PTPI)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2024-12-31, Petros Pharmaceuticals, Inc. reported revenue of $5.11M. Revenue fell 12.2% from the prior annual period.
Key ratios (year ended 2024-12-31)
76.3%
Gross margin
-90.5%
Operating margin
-280.1%
Net margin
-12.2%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.